Argus upgraded Elevance Health (ELV) to Buy from Hold with a $450 price target
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELV:
- Dr. Oz says would address ‘upcoding,’ Fierce Healthcare reports
- Oz grilled at Senate confirmation hearing, NY Times reports
- CMS rule proposal another challenge for insures, says Wells Fargo
- Elevance Health Reaffirms 2025 Earnings Guidance to Investors
- Elevance Health to reaffirm FY25 adjusted EPS guidance of $34.15-$34.85
Questions or Comments about the article? Write to editor@tipranks.com